Importance of 5/6-aryl substitution on the pharmacological profile of 4'-((2-propyl-1H-benzo[d]imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid derived PPARγ agonists.

V. Obermoser,R. Mauersberger,D. Schuster,Monika Czifersky,M. Lipova,Monika Siegl,U. Kintscher,R. Gust
DOI: https://doi.org/10.1016/j.ejmech.2016.11.051
IF: 7.088
2017-01-27
European Journal of Medicinal Chemistry
Abstract:
What problem does this paper attempt to address?